Who
Chen-Ming Yu
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, TCGX Acquisition; 10% owner, Surrozen; Interim COO, Sagent Pharmaceuticals.
In numbers
- Trades disclosed
- 6
- Buys
- 1
- Sells
- 1
- Bought
- $16K
- Sold
- $6.9M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 20 Apr 2011
- Last trade
- 6 Aug 2026
- Last filed
- 6 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 6 Aug 2026 | TCGX TCGX AcquisitionFunds, Shells & SPACs | SEC FORM 4 Code A | $4.4M436,250 at $10.00 | filing |
| 22 Jul 2026filed 24 Jul 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $3.5M162,500 at $21.25 | filing |
| 22 Jul 2026filed 24 Jul 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $3.5M162,500 at $21.25 | filing |
| 7 Sep 2012filed 11 Sep 2012 | Sagent Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —105,000 at $0.00 | filing |
| 22 Feb 2012filed 24 Feb 2012 | Sagent Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —2,268 at $0.00 | filing |
| 20 Apr 2011filed 25 Apr 2011 | Sagent Holding Co | SEC FORM 4 Bought | $16K1,000 at $16.00 | filing |
News
Head to Head Review: Surrozen (NASDAQ:SRZN) vs. AbCellera Biologics (NASDAQ:ABCL)SRZN · tickerreport.com · 14 Oct 2026Surrozen Sees Unusually Large Options Volume (NASDAQ:SRZN)SRZN · themarketsdaily.com · 12 Oct 2026Head to Head Analysis: Whitehawk Therapeutics (NASDAQ:WHWK) vs. Surrozen (NASDAQ:SRZN)SRZN · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Chen-Ming Yu; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.